Loblaw Companies earnings date
Loblaw Companies (LBLCF) Q3 2026 Earnings Report
LBLCF Q3 2026 EPS Results
- Actual EPS
- $0.52
- Consensus EPS
- $0.52
- Beat/Miss
- Met expectations
- One Year Ago EPS
- $0.48
LBLCF Q3 2026 Revenue Results
- Actual Revenue
- $19.86B
- Expected Revenue
- $13.86B
- Beat/Miss
- Beat by +$6.00B
- YoY Revenue Growth
- +46.78%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/19/2026
- Time
- Before Open
- Conference Call
- Thursday, November 19, 2026
Loblaw Companies's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was strongly positive overall. Loblaw reported broad-based revenue and earnings growth, stable or improved margins, strong performance in drug retail, discount stores, digital channels, and complementary businesses, as well as continued market-share gains and a reaffirmed full-year outlook. The main challenges were modest food same-store sales, fuel-related pressure on consumer spending and traffic, supplier price-increase requests, lower year-over-year free cash flow, and the temporary impact of including only one month of EQ Bank earnings.
Loblaw said it remains confident in its full-year outlook, expects its retail business to grow earnings faster than sales, and continues to expect adjusted EPS growth in the high single digits, including the impact of recognizing only one month of EQ Bank earnings in Q3 and excluding the impact of the 53rd week last year; it plans to invest approximately CAD 2.4 billion in capital expenditures this year and remains on track to open about 75 stores this year. From Q4 2026 onwards, it will include its proportionate share of a full quarter of EQ Bank’s earnings. Food same-store sale is currently trending higher than in Q3, and the company expects to have 95 front-store food locations completed by year-end, with almost 500 stores expected to carry multicultural products by year-end and an additional 300 stores next year. For 2027, Loblaw said it will be at least as aggressive on new discount stores, CapEx will come down, and it will increase buybacks, although it is too early to say by how much for both numbers.
- Strong Retail Revenue and Earnings GrowthThird-quarter retail sales increased by CAD 700 million, or 3.6%, to CAD 19.9 billion. Retail adjusted EBITDA increased 6.9%, retail adjusted EBITDA margin expanded by 30 basis points, and adjusted diluted net earnings per share from continuing operations grew 15.6%.
- Consolidated EPS Growth Despite Partial EQ Bank ContributionFollowing the July 1, 2026 closing of the EQ Bank transaction, Q3 included only one month of EQ Bank earnings, representing CAD 9 million of adjusted income. Including this timing-related headwind, total consolidated adjusted EPS still grew 8.8%; management said EPS would have grown in the low double digits if three months of EQ Bank earnings had been included. From Q4 2026 onward, results will include a full quarter of EQ Bank earnings.
- GAAP EPS Included CAD 400 Million PC Financial GainGAAP diluted net earnings per common share were CAD 1.03, including a CAD 400 million post-tax gain from the sale of PC Financial.
- Food Retail Sales and Market Share GrowthAbsolute food sales increased 2.8%, food same-store sales grew 0.6%, and Loblaw grew its market share. Internal CPI-like food inflation was in line with Canada's grocery CPI.
- Strong Performance from Discount and New StoresHard discount banners delivered comparable sales growth above 2%. Loblaw opened 18 stores in Q3, including nine hard discount stores, seven new Shoppers Drug Mart locations, one City Market in Vancouver, and the Empress Walk T&T location in Toronto. These openings increased net retail square footage by 1.8%, and stores opened in 2025 that have entered the comparable-sales base are growing double digits. The company remains on track to open about 75 stores in 2026.
- Positive Outlook for Food Same-Store SalesFood same-store sales were trending higher in Q4 than in Q3, although management noted that the holiday season remains an important factor. Management also said discount comparable sales accelerated at the start of Q4.
- Strong Drug Retail and Pharmacy GrowthTotal drug retail sales increased 5.7%, while drug retail same-store sales increased 4.8%. Pharmacy and healthcare services same-store sales grew 7.6%, led by specialty and chronic prescriptions.
- GLP-1 Category MomentumGeneric GLP-1 drugs are increasing awareness through their lower price point and driving a significant increase in demand across the overall GLP-1 category. Loblaw is selling all the generic products it can obtain, while novel categories are also continuing to grow faster. Management said penetration should grow as more products become available.
- Positive Front-Store PerformanceFront-store same-store sales increased 1.6%, supported by beauty and over-the-counter products. Management said it remains pleased with the underlying strength and profitability of the front-store business.
- Digital Sales GrowthOnline sales increased 16.9% in the quarter. Management said Loblaw remains the leader in online grocery in Canada and is focused on improving convenience through PC Express, delivery partners, and its stores.
- Stable Gross Margin and Improved SG&A RateGross margin increased by 20 basis points to 31.3%, primarily driven by strategic initiatives including the scaling of high-growth complementary businesses and shrink. The SG&A rate improved by 20 basis points to 20%. Operating leverage from higher sales more than offset incremental expenses related to new-store openings and the ramp-up of the automated distribution facility.
- Strong Cash Generation and Share RepurchasesFree cash flow from continuing operations was CAD 324 million in the quarter. Loblaw repurchased CAD 524 million of common shares in Q3, bringing year-to-date repurchases to CAD 1.7 billion. Management said the balance sheet remains extremely strong and provides flexibility to invest in the business and return capital to shareholders.
- QHR Technologies Sale Supports Healthcare InnovationLoblaw sold its interest in QHR Technologies to LGI Healthcare Solutions. Management said the transaction supports continued growth and innovation in Canada's healthcare sector, while Shoppers Drug Mart will maintain a commercial and strategic relationship with QHR and LGI. The transaction will result in a pre-tax gain on sale in Q4 2026.
- Full-Year Outlook ReaffirmedManagement remains confident in delivering its full-year outlook. The company continues to expect retail earnings to grow faster than sales and adjusted EPS growth in the high single digits. The outlook includes the impact of recognizing only one month of EQ Bank earnings in Q3 and excludes the impact of last year's 53rd week.
- Continued Investment in Stores and DistributionLoblaw plans to invest approximately CAD 2.4 billion in capital expenditures in 2026, focused on stores and the distribution network. Management said the new-store strategy is working and that it is continuing to invest while delivering current financial results.
- Expansion of Affordable Food OfferingsLoblaw celebrated the opening of its 350th No Frills store. Real Atlantic Superstore lowered prices on more than 4,200 products; management said these changes could represent approximately CAD 300 in annual savings for a family of four. The company reported higher total sales of the lower-priced items, higher customer traffic, and higher total sales in those stores.
- AMS Sourcing Scale and Buying PowerLoblaw has sourced over CAD 1 billion through the AMS Sourcing buying alliance this year, with plans to grow that further. Management said the alliance provides access to a global supply base and knowledge sharing, allowing the company to invest in price while keeping margins stable.
- T&T Store Performance and U.S. ExpansionThe Erin Mills and Empress Walk T&T stores are exceeding management's high expectations. Sales at the Empress Walk location more than doubled the sales of the Loblaw store it replaced. Loblaw also opened its fourth U.S. T&T location in San Francisco and expects to open another location in Chino Hills in the greater Los Angeles area in December.
- Expansion of Shoppers Front-Store OfferingsThe Shoppers front-store food pilot expanded from three stores to 18 locations, with 95 locations expected to be completed by year-end. Loblaw reported a strong sales lift in newly added products and higher unit sales across existing food products. Multicultural food products are expected in almost 500 stores by year-end and an additional 300 stores next year.
- Expanded Healthcare AccessLoblaw is continuing to invest in making healthcare more accessible and convenient, particularly in communities where access to primary care can be challenging. Management said pharmacies are increasingly providing a broader range of healthcare services beyond prescription pickup.
- AI-Powered Customer and Healthcare ToolsPC Chat, an AI-powered health assistant launched with PC Health and Shoppers Drug Mart, received more than 4 million questions and facilitated hundreds of thousands of pharmacy appointments in its first two months. Loblaw also launched a reimagined PC Optimum app combining commerce apps, conversational AI, personalized offers, and shopping across its businesses.
- Leadership in Agentic CommerceLoblaw was the first retailer to bring grocery shopping to ChatGPT, subsequently expanded to Google Gemini, and became the first Canadian retailer to integrate with Meta's Muse. Management said these investments are intended to help customers manage everyday shopping, including restocking, budgeting, and placing orders with approval.
- Early Customer Engagement with Digital InnovationsManagement said ChatGPT users are increasingly searching for recipes and help solving the evening-meal problem. In the first days following the new PC app launch, 50% of new Shoppers e-commerce customers were either dormant or completely new customers. Management said it was too early to quantify the contribution to same-store sales.
- High-Double-Digit Growth in Complementary BusinessesLoblaw's high-growth complementary businesses continued to grow at high double-digit rates in the quarter.
- Expected 2027 Capital Allocation FlexibilityManagement said capital expenditures will come down in 2027 and that it intends to increase buybacks, although the amounts will be provided with the Q4 results.
LBLCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 0.45- | 0.47 | ― | ― |
| Nov 19, 2026 | 2026 (Q3) | 0.520.52 | 0.48 | 7.25% (+0.03) | |
| Jul 30, 2026 | 2026 (Q2) | 0.450.46 | 0.42 | 10.00% (+0.04) | |
| May 06, 2026 | 2026 (Q1) | 0.360.36 | 0.33 | 10.64% (+0.03) | |
| Feb 25, 2026 | 2025 (Q4) | 0.460.47 | 0.38 | 21.82% (+0.08) | |
| Nov 12, 2025 | 2025 (Q3) | 0.470.48 | 0.44 | 10.40% (+0.05) | |
| Jul 24, 2025 | 2025 (Q2) | 0.410.42 | 0.38 | 11.52% (+0.04) | |
| Apr 30, 2025 | 2025 (Q1) | 0.330.33 | 0.3 | 9.30% (+0.03) | |
| Feb 20, 2025 | 2024 (Q4) | 0.390.38 | 0.35 | 10.00% (+0.03) | |
| Nov 13, 2024 | 2024 (Q3) | 0.430.44 | 0.39 | 10.62% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

